Press release

DuPont Biomaterials Leader Michael Saltzberg to Speak at The Future of Materials Summit

November 13 2017

The Economist Events will host the summit on November 13-14 in Luxembourg, where Saltzberg will address “Best Practices for New Materials' Development”

WILMINGTON, Del., Nov. 13, 2017 - DuPont Industrial Biosciences (DuPont) announced that Michael Saltzberg, Ph.D., global business director of DuPont Biomaterials, will participate in The Future of Materials Summit, beginning today in Luxembourg. Saltzberg will join other materials business leaders for a discussion on "Best Practices for New Materials' Development," led by Geoffrey Carr, science editor at The Economist and chair of the Summit.

As the leader of DuPont's global biomaterials programs and business development, Saltzberg spearheads the development and commercialization of renewably sourced biochemicals and biomaterials based on plants rather than petroleum.

"Materials suppliers play a critical role in increasing the sustainability of supply chains across the industries that we serve, and we believe making high-performance and cost-efficient materials from plant-based feedstocks is part of the solution," said Saltzberg. "I am looking forward to sharing the latest in DuPont's biomaterials innovations with the group that The Economist has brought together for this Summit."

One of DuPont's core innovations in this space is Bio-PDO™ propanediol - a bio-based ingredient used in a variety of materials across a number of industries. DuPont™ Sorona® is one of those materials - a patented polymer that offers customers a more sustainable solution for fibers and other applications with better performance in key parameters than competing petroleum-based materials. Sorona® is used around the world in the textile, carpeting, and automotive markets - bringing softness, crush resistance and stretch to a growing list of products, not to mention its superior life cycle compared to the petroleum-based products it often replaces.

In early 2016, DuPont partnered with Archer Daniels Midland Company (ADM) to launch a breakthrough process to produce a bio-based monomer - furan dicarboxylic methyl ester (FDME) - from a renewable feedstock. One of the first polymers under development is polytrimethylene furandicarboxylate (PTF), a novel polyester made by combining FDME and Bio-PDO™. PTF is a 100-percent renewable that - when used to make bottles and other beverage packages - substantially improves gas-barrier properties compared to other polyesters. This kind of innovation is central to DuPont's approach: by developing this renewably sourced monomer, the beverage industry will be able to create effective packages using less polymer than is required for current designs, resulting in significant benefits for customers and the environment.

At the Summit, Dr. Saltzberg also will address DuPont's research into the commercialization of a completely new way to make high-performance polymers directly from sugar. This novel process - as illustrated in this video - uses an enzymatic process that closely mimics the way nature builds polymers like cellulose. He also plans to speak to materials manufacturers' responsibility to enable environmentally friendly end-of-life solutions, acknowledging that diverse applications and markets are best served by different technical solutions. DuPont's biomaterials team is working hard to help ensure that end-use markets are developed for recycled materials. For instance, DuPont recently announced a collaboration with Unifi to create high-performance, renewably sourced garment insulation made in part with recycled material and Sorona® polymer, offering leading apparel brands a new sustainable choice for cold-weather products.

The Future of Materials Summit - which runs through November 14 - will analyze the modern materials "ecosystem" from research and development, through supply chains, to business applications and end of use. The Economist is bringing together leading manufacturers, scientists, technologists and policymakers for a discussion intended to better understand what is happening, and to illuminate the role of novel materials in the manufacturing industries of the future.

DuPont's industry-leading excellence in the biomaterials industry has received a number of accolades over the past year, including the Platts Global Energy "Breakthrough Solution of the Year" award for the development partnership with ADM; Frost & Sullivan's award for 2017 European Company of the Year Award for bio-based materials; and, most recently, PLASTICS' 2017 Innovation in Bioplastics Award.

About DuPont Industrial Biosciences

DuPont Industrial Biosciences, a business unit of DowDuPont Specialty Products, works with customers across a wide range of industries to make products and industrial processes more efficient and sustainable. Through a unique combination of agriculture, biotechnology, chemistry and material science capabilities, we advance market-driven, bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. For updates about how DuPont Industrial Biosciences is helping customers deliver cost-effective products with superior performance and sustainability, follow @DuPontBiobased on Twitter or visit our website at

About DowDuPont Specialty Products

DowDuPont Specialty Products, a division of DowDuPont (NYSE: DWDP), is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, building and construction, health and wellness, food and worker safety. DowDuPont intends to separate the Specialty Products division into an independent, publicly traded company. More information can be found

# # #


DuPont™ Sorona® polymer contains 37 percent annually renewable plant-based ingredients by weight. The manufacture of Sorona® uses 30 percent less energy with 63 percent fewer greenhouse gas emissions as compared to Nylon 6, and 40 percent less energy and 56 percent fewer greenhouse gas emissions as compared to Nylon 6,6.

The DuPont Oval logo, DuPont and all products, unless otherwise noted, denoted with , ℠or ® are trademarks or registered trademarks of E. I. du Pont de Nemours and Company or its affiliates.

Cautionary Statement About Forward-Looking Statements

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words.

On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont de Nemours and Company ("DuPont") announced entry into an Agreement and Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement") under which the companies would combine in an all-stock merger of equals transaction (the "Merger Transaction"). Effective August 31, 2017, the Merger Transaction was completed and each of Dow and DuPont became subsidiaries of DowDuPont Inc. ("DowDuPont"). For more information, please see each of DowDuPont's, Dow's and DuPont's latest annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case may be, and the joint proxy statement/prospectus included in the registration statement on Form S-4 filed by DowDuPont with the SEC on March 1, 2016 (File No. 333-209869), as last amended on June 7, 2016, and declared effective by the SEC on June 9, 2016 (the "Registration Statement") in connection with the Merger Transaction.

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, including the intended separation of DowDuPont's agriculture, materials science and specialty products businesses in one or more tax efficient transactions on anticipated terms (the "Intended Business Separations"). Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause DowDuPont's, Dow's or DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) successful integration of the respective agriculture, materials science and specialty products businesses of Dow and DuPont, including anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, productivity actions, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined operations; (ii) impact of the divestitures required as a condition to consummation of the Merger Transaction as well as other conditional commitments; (iii) achievement of the anticipated synergies by DowDuPont's agriculture, materials science and specialty products businesses; (iv) risks associated with the Intended Business Separations, including those that may result from the comprehensive portfolio review undertaken by the DowDuPont board, changes and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances related to the Intended Business Separations, disruptions in the financial markets or other potential barriers; (v) the risk that disruptions from the Intended Business Separations will harm DowDuPont's business (either directly or as conducted by and through Dow or DuPont), including current plans and operations; (vi) the ability to retain and hire key personnel; (vii) potential adverse reactions or changes to business relationships resulting from the completion of the merger or the Intended Business Separations; (viii) uncertainty as to the long-term value of DowDuPont common stock; (ix) continued availability of capital and financing and rating agency actions; (x) legislative, regulatory and economic developments; (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the Intended Business Separations that could affect the company's financial performance and (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management's response to any of the aforementioned factors. These risks, as well as other risks associated with the merger and the Intended Business Separations, are more fully discussed in (1) the Registration Statement and (2) the current, quarterly and annual reports filed with the SEC by DowDuPont and to the extent incorporated by reference into the Registration Statement, by Dow and DuPont. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont's, Dow's or DuPont's consolidated financial condition, results of operations, credit rating or liquidity. None of DowDuPont, Dow or DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.


DuPont Industrial Biosciences
Wendy Rosen

Tagged: SaltzbergBiomaterialsBio-basedBio-PDO
This site uses functionality that older versions of Internet Explorer does not support. Please switch or upgrade your browser.